TY - JOUR
T1 - Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents
AU - Chen, Tsung Chih
AU - Yu, Dah Shyong
AU - Huang, Kuo Feng
AU - Fu, Yung Chien
AU - Lee, Chia Chung
AU - Chen, Chun Liang
AU - Huang, Fong Chun
AU - Hsieh, Hsi Hsien
AU - Lin, Jing Jer
AU - Huang, Hsu Shan
PY - 2013
Y1 - 2013
N2 - By using fragment-based design strategies, a series of 2-thio-substituted anthra[1,2-d]imidazole-6,11-diones were synthesized and evaluated for hTERT repressing activities, cell proliferations, and NCI 60-cell panel assay. Compounds 2, 3, 4, 11, 15 and 35 were selected by the NCI and 3, 4, 11 and 15 represent the GI50, TGI and LC50, respectively. Among them, all were moderate selectivity toward leukemia cancer except for 4 exhibited distinctive selectivity of CNS and renal cancer with 7.403 and 6.475. The overall of test compounds exhibited different cytostatic and cytotoxic activities for further developing potential application as anticancer drugs.
AB - By using fragment-based design strategies, a series of 2-thio-substituted anthra[1,2-d]imidazole-6,11-diones were synthesized and evaluated for hTERT repressing activities, cell proliferations, and NCI 60-cell panel assay. Compounds 2, 3, 4, 11, 15 and 35 were selected by the NCI and 3, 4, 11 and 15 represent the GI50, TGI and LC50, respectively. Among them, all were moderate selectivity toward leukemia cancer except for 4 exhibited distinctive selectivity of CNS and renal cancer with 7.403 and 6.475. The overall of test compounds exhibited different cytostatic and cytotoxic activities for further developing potential application as anticancer drugs.
KW - Anthra 12-dimidazole-611-dione
KW - Cytostatic and cytotoxic activities
KW - NCI 60-cell panel assay
KW - Selectivity ratio
UR - http://www.scopus.com/inward/record.url?scp=84883877783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883877783&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2013.06.058
DO - 10.1016/j.ejmech.2013.06.058
M3 - Article
C2 - 24051300
AN - SCOPUS:84883877783
SN - 0223-5234
VL - 69
SP - 278
EP - 293
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -